Wealth Alliance Genmab A/S Transaction History

Wealth Alliance

$818 Million
Q3 2024

A detailed history of Wealth Alliance transactions in Genmab A/S stock. As of the latest transaction made, Wealth Alliance holds 10,043 shares of GMAB stock, worth $206,785. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,043

Holding current value

$206,785

% of portfolio

0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$23.84 - $28.48 $239,425 - $286,024	10,043 New	10,043 $244,000
Q4 2023 Jan 30, 2024	SELL	$27.94 - $35.44 $64,206 - $81,441	-2,298 Reduced 21.47%	8,403 $267,000
Q3 2023 Nov 09, 2023	BUY	$35.27 - $42.24 $4,726 - $5,660	134 Added 1.27%	10,701 $377,000
Q2 2023 Aug 02, 2023	BUY	$37.4 - $42.94 $11,182 - $12,839	299 Added 2.91%	10,567 $401,000
Q1 2023 May 10, 2023	BUY	$34.88 - $43.22 $4,150 - $5,143	119 Added 1.17%	10,268 $387,000
Q4 2022 Feb 13, 2023	SELL	$33.8 - $47.06 $59,454 - $82,778	-1,759 Reduced 14.77%	10,149 $430,000
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $131,501 - $1.56 Million	4,172 Added 53.93%	11,908 $383,000
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $43,893 - $63,100	-1,636 Reduced 17.46%	7,736 $251,000
Q1 2022 May 10, 2022	BUY	$30.95 - $39.68 $17,084 - $21,903	552 Added 6.26%	9,372 $339,000
Q4 2021 Feb 14, 2022	SELL	$35.87 - $47.12 $41,250 - $54,188	-1,150 Reduced 11.53%	8,820 $349,000
Q3 2021 Nov 12, 2021	BUY	$41.55 - $48.72 $86,174 - $101,045	2,074 Added 26.27%	9,970 $436,000
Q2 2021 Aug 16, 2021	SELL	$32.88 - $44.57 $59,282 - $80,359	-1,803 Reduced 18.59%	7,896 $322,000
Q1 2021 May 18, 2021	SELL	$30.92 - $44.4 $12,615 - $18,115	-408 Reduced 4.04%	9,699 $318,000
Q4 2020 Feb 11, 2021	BUY	$33.66 - $40.76 $14,002 - $16,956	416 Added 4.29%	10,107 $410,000
Q3 2020 Nov 13, 2020	SELL	$33.07 - $38.68 $18,453 - $21,583	-558 Reduced 5.44%	9,691 $355,000
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $205,492 - $347,338	10,249 New	10,249 $347,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.

Account